These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 39287805)

  • 41. Multivariate analysis of clinical prognostic factors in children with intracranial ependymomas.
    Jaing TH; Wang HS; Tsay PK; Tseng CK; Jung SM; Lin KL; Lui TN
    J Neurooncol; 2004 Jul; 68(3):255-61. PubMed ID: 15332330
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Radiology Profile as a Potential Instrument to Differentiate Between Posterior Fossa Ependymoma (PF-EPN) Group A and B.
    Yonezawa U; Karlowee V; Amatya VJ; Takayasu T; Takano M; Takeshima Y; Sugiyama K; Kurisu K; Yamasaki F
    World Neurosurg; 2020 Aug; 140():e320-e327. PubMed ID: 32428725
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Natural progression of an unresected supratentorial ependymoma.
    Wang HC; Hertzog JH; O'Donnell HD; Walter AW
    Pediatr Neurosurg; 2008; 44(1):75-8. PubMed ID: 18097198
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinicopathological evaluation of PD-L1 expression and cytotoxic T-lymphocyte infiltrates across intracranial molecular subgroups of ependymomas: are these tumors potential candidates for immune check-point blockade?
    Nambirajan A; Malgulwar PB; Sharma A; Boorgula MT; Doddamani R; Singh M; Suri V; Sarkar C; Sharma MC
    Brain Tumor Pathol; 2019 Oct; 36(4):152-161. PubMed ID: 31388782
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic value of H3K27me3 in children with ependymoma.
    Han Z; Kang P; Zhang H; Liao Z; Li C; Gong J; Liu W; Tian Y
    Pediatr Blood Cancer; 2020 Mar; 67(3):e28121. PubMed ID: 31850684
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Natural history and role of radiation in patients with supratentorial and infratentorial WHO grade II ependymomas: results from a population-based study.
    Aizer AA; Ancukiewicz M; Nguyen PL; Macdonald SM; Yock TI; Tarbell NJ; Shih HA; Loeffler JS; Oh KS
    J Neurooncol; 2013 Dec; 115(3):411-9. PubMed ID: 24057324
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment trends and overall survival in patients with grade II/III ependymoma: The role of tumor grade and location.
    Lopez-Rivera V; Dono A; Abdelkhaleq R; Sheth SA; Chen PR; Chandra A; Ballester LY; Esquenazi Y
    Clin Neurol Neurosurg; 2020 Dec; 199():106282. PubMed ID: 33045626
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cross-Species Genomics Reveals Oncogenic Dependencies in ZFTA/C11orf95 Fusion-Positive Supratentorial Ependymomas.
    Zheng T; Ghasemi DR; Okonechnikov K; Korshunov A; Sill M; Maass KK; Benites Goncalves da Silva P; Ryzhova M; Gojo J; Stichel D; Arabzade A; Kupp R; Benzel J; Taya S; Adachi T; Shiraishi R; Gerber NU; Sturm D; Ecker J; Sievers P; Selt F; Chapman R; Haberler C; Figarella-Branger D; Reifenberger G; Fleischhack G; Rutkowski S; Donson AM; Ramaswamy V; Capper D; Ellison DW; Herold-Mende CC; Schüller U; Brandner S; Driever PH; Kros JM; Snuderl M; Milde T; Grundy RG; Hoshino M; Mack SC; Gilbertson RJ; Jones DTW; Kool M; von Deimling A; Pfister SM; Sahm F; Kawauchi D; Pajtler KW
    Cancer Discov; 2021 Sep; 11(9):2230-2247. PubMed ID: 33879448
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gain.
    Gojo J; Lötsch D; Spiegl-Kreinecker S; Pajtler KW; Neumayer K; Korbel P; Araki A; Brandstetter A; Mohr T; Hovestadt V; Chavez L; Kirchhofer D; Ricken G; Stefanits H; Korshunov A; Pfister SM; Dieckmann K; Azizi AA; Czech T; Filipits M; Kool M; Peyrl A; Slavc I; Berger W; Haberler C
    Neuro Oncol; 2017 Sep; 19(9):1183-1194. PubMed ID: 28371821
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ependymomas in infancy: underlying genetic alterations, histological features, and clinical outcome.
    Jünger ST; Andreiuolo F; Mynarek M; Dörner E; Zur Mühlen A; Rutkowski S; von Bueren AO; Pietsch T
    Childs Nerv Syst; 2020 Nov; 36(11):2693-2700. PubMed ID: 32474813
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Classification and neuroimaging of ependymal tumors.
    Mu W; Dahmoush H
    Front Pediatr; 2023; 11():1181211. PubMed ID: 37287627
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Verification of the diagnosis of supratentorial ependymomas by real-time PCR].
    Galstyan SA; Telysheva EN; Lavrinovich AO; Shaikhaev EG; Snigireva GP; Petrova EI; Gorelyshev SK; Zheludkova OG; Kushel YV; Kumirova EV; Ryzhova MV
    Arkh Patol; 2023; 85(3):5-11. PubMed ID: 37272434
    [TBL] [Abstract][Full Text] [Related]  

  • 53. cIMPACT-NOW update 7: advancing the molecular classification of ependymal tumors.
    Ellison DW; Aldape KD; Capper D; Fouladi M; Gilbert MR; Gilbertson RJ; Hawkins C; Merchant TE; Pajtler K; Venneti S; Louis DN
    Brain Pathol; 2020 Sep; 30(5):863-866. PubMed ID: 32502305
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of Molecular Subgroups on Prognosis and Survival Outcomes in Posterior Fossa Ependymomas: A Retrospective Study of 412 Cases.
    Wang B; Yan M; Han B; Liu X; Liu P
    Neurosurgery; 2024 Sep; 95(3):651-659. PubMed ID: 38529997
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular genetics of ependymomas and pediatric diffuse gliomas: a short review.
    Nobusawa S; Hirato J; Yokoo H
    Brain Tumor Pathol; 2014 Oct; 31(4):229-33. PubMed ID: 25182241
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA study.
    Chapman RJ; Ghasemi DR; Andreiuolo F; Zschernack V; Espariat AT; Buttarelli FR; Giangaspero F; Grill J; Haberler C; Paine SML; Scott I; Jacques TS; Sill M; Pfister S; Kilday JP; Leblond P; Massimino M; Witt H; Modena P; Varlet P; Pietsch T; Grundy RG; Pajtler KW; Ritzmann TA
    Neuro Oncol; 2023 Oct; 25(10):1871-1882. PubMed ID: 36916248
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Supratentorial Cortical Ependymomas: A Retrospective Series of 13 Cases at a Single Center.
    Wang M; Zhang R; Liu X; Li D; Zhao P; Zuo Y; Zhang P; Wang J; Sun H
    World Neurosurg; 2018 Apr; 112():e772-e777. PubMed ID: 29408575
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Targeting fibroblast growth factor receptors to combat aggressive ependymoma.
    Lötsch D; Kirchhofer D; Englinger B; Jiang L; Okonechnikov K; Senfter D; Laemmerer A; Gabler L; Pirker C; Donson AM; Bannauer P; Korbel P; Jaunecker CN; Hübner JM; Mayr L; Madlener S; Schmook MT; Ricken G; Maaß K; Grusch M; Holzmann K; Grasl-Kraupp B; Spiegl-Kreinecker S; Hsu J; Dorfer C; Rössler K; Azizi AA; Foreman NK; Peyrl A; Haberler C; Czech T; Slavc I; Filbin MG; Pajtler KW; Kool M; Berger W; Gojo J
    Acta Neuropathol; 2021 Aug; 142(2):339-360. PubMed ID: 34046693
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ZFTA-YAP1 fusion-positive ependymoma can occur in the spinal cord: Letter to the editor.
    Lim KY; Lee KH; Phi JH; Yun H; Won JK; Choi SH; Park SH
    Brain Pathol; 2022 Jan; 32(1):e13020. PubMed ID: 34506076
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A clinicopathological analysis of supratentorial ependymoma, ZFTA fusion-positive: utility of immunohistochemical detection of CDKN2A alterations and characteristics of the immune microenvironment.
    Hashimoto N; Suzuki T; Ishizawa K; Nobusawa S; Yokoo H; Nishikawa R; Yasuda M; Sasaki A
    Brain Tumor Pathol; 2023 Jul; 40(3):163-175. PubMed ID: 37322295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.